|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.88 CHF | -0.48% |
|
+1.50% | +20.50% |
| 12-03 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
| 12-03 | Sector Update: Health Care | MT |
| Capitalization | 256B 219B 205B 192B 357B 22,971B 386B 2,406B 928B 10,854B 960B 939B 39,577B | P/E ratio 2025 * |
18.4x | P/E ratio 2026 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise value | 276B 236B 221B 206B 384B 24,763B 416B 2,594B 1,001B 11,701B 1,035B 1,013B 42,664B | EV / Sales 2025 * |
4.98x | EV / Sales 2026 * | 4.94x |
| Free-Float |
87.19% | Yield 2025 * |
3.07% | Yield 2026 * | 3.19% |
Last Transcript: Novartis AG
| 1 day | -0.45% | ||
| 1 week | +1.50% | ||
| Current month | +2.30% | ||
| 1 month | +7.42% | ||
| 3 months | +3.69% | ||
| 6 months | +12.15% | ||
| Current year | +20.50% |
| 1 week | 103.66 |  | 108.18 |
| 1 month | 99.45 | | 108.18 |
| Current year | 81.1 | | 108.18 |
| 1 year | 81.1 | | 108.18 |
| 3 years | 73.74 | | 108.18 |
| 5 years | 72.84 | | 108.18 |
| 10 years | 65.09 | | 108.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 49 | 2018-01-31 | |
| Director of Finance/CFO | 60 | 2013-04-23 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 63 | 2022-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 66 | 2014-12-31 |
Liz Doherty
BRD | Director/Board Member | 68 | 2015-12-31 |
Ton Büchner
BRD | Director/Board Member | 60 | 2015-12-31 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 10.4% | 121 M€ | -.--% | - |
| 5.57% | 26 M€ | +11.61% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.48% | +1.50% | +14.90% | +27.03% | 257B | |
| -1.85% | -5.67% | +22.25% | +174.71% | 925B | |
| -1.39% | -2.15% | +34.57% | +13.26% | 495B | |
| -0.66% | +0.44% | +29.61% | +39.51% | 407B | |
| -1.18% | -0.89% | +21.85% | +0.60% | 335B | |
| -1.31% | -4.48% | +25.25% | +20.90% | 283B | |
| -1.35% | -3.76% | -0.47% | -8.29% | 254B | |
| +0.66% | -2.67% | -60.91% | -31.82% | 211B | |
| -1.52% | -1.53% | +22.25% | +19.39% | 186B | |
| -1.90% | -2.56% | +33.88% | +39.37% | 155B | |
| Average | -1.19% | -1.46% | +14.32% | +29.47% | 350.9B | |
| Weighted average by Cap. | -1.31% | -2.23% | +18.38% | +56.51% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 55.38B 47.49B 44.41B 41.47B 77.22B 4,974B 83.65B 521B 201B 2,350B 208B 203B 8,570B | 56.64B 48.57B 45.42B 42.42B 78.99B 5,088B 85.57B 533B 206B 2,404B 213B 208B 8,766B |
| Net income | 14.37B 12.32B 11.52B 10.76B 20.03B 1,290B 21.7B 135B 52.15B 610B 53.92B 52.77B 2,223B | 14.27B 12.24B 11.44B 10.69B 19.9B 1,282B 21.56B 134B 51.8B 606B 53.56B 52.42B 2,208B |
| Net Debt | 19.95B 17.1B 16B 14.94B 27.82B 1,792B 30.13B 188B 72.41B 847B 74.87B 73.27B 3,087B | 24.17B 20.72B 19.38B 18.1B 33.7B 2,171B 36.51B 227B 87.74B 1,026B 90.71B 88.77B 3,740B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-04 | 106.88 CHF | -0.48% | 2,285,780 |
| 25-12-03 | 107.40 CHF | +1.13% | 3,088,727 |
| 25-12-02 | 106.20 CHF | +1.86% | 3,137,431 |
| 25-12-01 | 104.26 CHF | -0.21% | 2,732,533 |
| 25-11-28 | 104.48 CHF | -0.15% | 2,976,777 |
Delayed Quote Swiss Exchange, December 04, 2025 at 11:30 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition